Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1186/1471-2407-13-78.

Title:
Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma | BMC Cancer
Description:
Background Accumulating evidence indicates that components of the systemic inflammatory response, such as C-reactive protein (CRP) and neutrophil-to-lymphocyte ratio (NLR), have been associated with prognosis of various cancers. We aimed to elucidate whether CRP and NLR could serve as potential surrogate markers for response and survival in patients with hepatocellular carcinoma (HCC). Methods The study population consisted of 318 consecutive patients with HCC. CRP and NLR were measured at baseline with follow-up measurements. Results With the mean follow-up of 13.9 months, the median survival time was 13.8 months. Child-Pugh class, tumor size > 5 cm, tumor multiplicity, presence of portal vein thrombosis, α-fetoprotein > 200 ng/mL, CRP > 6.3 mg/L and NLR > 2.3 were identified as independent factors for worse survival of HCC (all p < 0.05). Patients with elevated CRP (> 6.3 mg/L) and elevated NLR (> 2.3) had a significantly shorter overall survival than those with low CRP and low NLR (all p < 0.001). The combined use of CRP and NLR provided incremental prognostic information. With significant inter-correlations, levels of CRP and NLR escalated with aggravating Child-Pugh class from A to C or progressing tumor stage from I to IV. CRP and NLR on baseline and serial measurements were well predictive of treatment response (p < 0.001). Conclusions CRP and NLR are independent indicators for survival in HCC patients, reflecting tumor burden and hepatic reserve. Their role in predicting tumor response and survival is more enhanced when used in combination. This study suggests that CRP and NLR are important prognostic biomarkers for HCC.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Science
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 8,170,836 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We see no obvious way the site makes money.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com might be cashing in, but we can't detect the method they're using.

Keywords {🔍}

crp, nlr, patients, tumor, survival, article, hcc, cancer, pubmed, google, scholar, levels, study, response, carcinoma, hepatocellular, prognostic, childpugh, class, cas, mgl, ratio, elevated, analysis, treatment, serum, creactive, protein, markers, significant, korea, figure, stage, months, neutrophiltolymphocyte, prognosis, factors, liver, inflammation, inflammatory, size, high, disease, data, role, incheon, group, authors, baseline, median,

Topics {✒️}

tumour t-lymphocyte infiltration tac-based loco-regional therapy tumor-infiltrating cd4+ t-lymphocytes open access article based loco-regional therapy c-reactive protein formation human c-reactive protein serum c-reactive protein malignant tumors/international union article download pdf pre-publication history kaplan-meier survival curves aggravating child-pugh class delta neutrophil–lymphocyte ratio lymphocyte-mediated immune response loco-regional therapy significant positive inter-correlation /ii/iii/iva/ivb jung hyun kwon c-reactive protein chul seung kay accumulated il-17-recruited neutrophils elevated serum α-fetoprotein cox regression model privacy choices/manage cookies jeong won jang authors’ original file key proangiogenic factor hepatocellular carcinoma cells full access human cholangiocellular carcinoma kaplan-meier method liver disease progressed kyu won chung liver cancer surgery paracrine regulation mediated child-pugh class portal vein thrombosis renal cell cancer child-pugh classes present findings show bmc cancer 13 factors affecting recurrence anti-apoptotic activity stimulates proangiogenic activity understand inflammatory process key prognostic factors present study focused log-rank test systemic inflammatory response

Questions {❓}

  • Muller I, Munder M, Kropf P, Hansch GM: Polymorphonuclear neutrophils and T lymphocytes: strange bedfellows or brothers in arms?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma
         description:Accumulating evidence indicates that components of the systemic inflammatory response, such as C-reactive protein (CRP) and neutrophil-to-lymphocyte ratio (NLR), have been associated with prognosis of various cancers. We aimed to elucidate whether CRP and NLR could serve as potential surrogate markers for response and survival in patients with hepatocellular carcinoma (HCC). The study population consisted of 318 consecutive patients with HCC. CRP and NLR were measured at baseline with follow-up measurements. With the mean follow-up of 13.9 months, the median survival time was 13.8 months. Child-Pugh class, tumor size &gt; 5 cm, tumor multiplicity, presence of portal vein thrombosis, α-fetoprotein &gt; 200 ng/mL, CRP &gt; 6.3 mg/L and NLR &gt; 2.3 were identified as independent factors for worse survival of HCC (all p &lt; 0.05). Patients with elevated CRP (&gt; 6.3 mg/L) and elevated NLR (&gt; 2.3) had a significantly shorter overall survival than those with low CRP and low NLR (all p &lt; 0.001). The combined use of CRP and NLR provided incremental prognostic information. With significant inter-correlations, levels of CRP and NLR escalated with aggravating Child-Pugh class from A to C or progressing tumor stage from I to IV. CRP and NLR on baseline and serial measurements were well predictive of treatment response (p &lt; 0.001). CRP and NLR are independent indicators for survival in HCC patients, reflecting tumor burden and hepatic reserve. Their role in predicting tumor response and survival is more enhanced when used in combination. This study suggests that CRP and NLR are important prognostic biomarkers for HCC.
         datePublished:2013-02-15T00:00:00Z
         dateModified:2013-02-15T00:00:00Z
         pageStart:1
         pageEnd:9
         license:https://creativecommons.org/licenses/by/2.0
         sameAs:https://doi.org/10.1186/1471-2407-13-78
         keywords:
            Inflammation markers
            Neutrophil-to-lymphocyte ratio
            C-reactive protein
            Hepatocellular carcinoma
            Survival
            Cancer Research
            Oncology
            Surgical Oncology
            Health Promotion and Disease Prevention
            Biomedicine
            general
            Medicine/Public Health
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-13-78/MediaObjects/12885_2012_Article_3702_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-13-78/MediaObjects/12885_2012_Article_3702_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-13-78/MediaObjects/12885_2012_Article_3702_Fig3_HTML.jpg
         isPartOf:
            name:BMC Cancer
            issn:
               1471-2407
            volumeNumber:13
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Byong Sun Oh
               affiliation:
                     name:Incheon St. Mary’s Hospital
                     address:
                        name:Department of Internal Medicine, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, South Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jeong Won Jang
               affiliation:
                     name:Incheon St. Mary’s Hospital
                     address:
                        name:Department of Internal Medicine, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, South Korea
                        type:PostalAddress
                     type:Organization
                     name:The Catholic University of Korea
                     address:
                        name:Division of Hepatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seocho-gu, South Korea
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Jung Hyun Kwon
               affiliation:
                     name:Incheon St. Mary’s Hospital
                     address:
                        name:Department of Internal Medicine, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, South Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Chan Ran You
               affiliation:
                     name:Incheon St. Mary’s Hospital
                     address:
                        name:Department of Internal Medicine, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, South Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kyu Won Chung
               affiliation:
                     name:Incheon St. Mary’s Hospital
                     address:
                        name:Department of Internal Medicine, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, South Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Chul Seung Kay
               affiliation:
                     name:The Catholic University of Korea
                     address:
                        name:Department of Radiation Oncology, The Catholic University of Korea, Incheon, South Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hyun Suk Jung
               affiliation:
                     name:Incheon St. Mary’s Hospital
                     address:
                        name:Department of Radiology, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, South Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Seungok Lee
               affiliation:
                     name:The Catholic University of Korea, Incheon St. Mary’s Hospital
                     address:
                        name:Department of Laboratory Medicine, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, South Korea
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma
      description:Accumulating evidence indicates that components of the systemic inflammatory response, such as C-reactive protein (CRP) and neutrophil-to-lymphocyte ratio (NLR), have been associated with prognosis of various cancers. We aimed to elucidate whether CRP and NLR could serve as potential surrogate markers for response and survival in patients with hepatocellular carcinoma (HCC). The study population consisted of 318 consecutive patients with HCC. CRP and NLR were measured at baseline with follow-up measurements. With the mean follow-up of 13.9 months, the median survival time was 13.8 months. Child-Pugh class, tumor size &gt; 5 cm, tumor multiplicity, presence of portal vein thrombosis, α-fetoprotein &gt; 200 ng/mL, CRP &gt; 6.3 mg/L and NLR &gt; 2.3 were identified as independent factors for worse survival of HCC (all p &lt; 0.05). Patients with elevated CRP (&gt; 6.3 mg/L) and elevated NLR (&gt; 2.3) had a significantly shorter overall survival than those with low CRP and low NLR (all p &lt; 0.001). The combined use of CRP and NLR provided incremental prognostic information. With significant inter-correlations, levels of CRP and NLR escalated with aggravating Child-Pugh class from A to C or progressing tumor stage from I to IV. CRP and NLR on baseline and serial measurements were well predictive of treatment response (p &lt; 0.001). CRP and NLR are independent indicators for survival in HCC patients, reflecting tumor burden and hepatic reserve. Their role in predicting tumor response and survival is more enhanced when used in combination. This study suggests that CRP and NLR are important prognostic biomarkers for HCC.
      datePublished:2013-02-15T00:00:00Z
      dateModified:2013-02-15T00:00:00Z
      pageStart:1
      pageEnd:9
      license:https://creativecommons.org/licenses/by/2.0
      sameAs:https://doi.org/10.1186/1471-2407-13-78
      keywords:
         Inflammation markers
         Neutrophil-to-lymphocyte ratio
         C-reactive protein
         Hepatocellular carcinoma
         Survival
         Cancer Research
         Oncology
         Surgical Oncology
         Health Promotion and Disease Prevention
         Biomedicine
         general
         Medicine/Public Health
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-13-78/MediaObjects/12885_2012_Article_3702_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-13-78/MediaObjects/12885_2012_Article_3702_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-13-78/MediaObjects/12885_2012_Article_3702_Fig3_HTML.jpg
      isPartOf:
         name:BMC Cancer
         issn:
            1471-2407
         volumeNumber:13
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Byong Sun Oh
            affiliation:
                  name:Incheon St. Mary’s Hospital
                  address:
                     name:Department of Internal Medicine, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, South Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jeong Won Jang
            affiliation:
                  name:Incheon St. Mary’s Hospital
                  address:
                     name:Department of Internal Medicine, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, South Korea
                     type:PostalAddress
                  type:Organization
                  name:The Catholic University of Korea
                  address:
                     name:Division of Hepatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seocho-gu, South Korea
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Jung Hyun Kwon
            affiliation:
                  name:Incheon St. Mary’s Hospital
                  address:
                     name:Department of Internal Medicine, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, South Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chan Ran You
            affiliation:
                  name:Incheon St. Mary’s Hospital
                  address:
                     name:Department of Internal Medicine, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, South Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kyu Won Chung
            affiliation:
                  name:Incheon St. Mary’s Hospital
                  address:
                     name:Department of Internal Medicine, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, South Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chul Seung Kay
            affiliation:
                  name:The Catholic University of Korea
                  address:
                     name:Department of Radiation Oncology, The Catholic University of Korea, Incheon, South Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hyun Suk Jung
            affiliation:
                  name:Incheon St. Mary’s Hospital
                  address:
                     name:Department of Radiology, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, South Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Seungok Lee
            affiliation:
                  name:The Catholic University of Korea, Incheon St. Mary’s Hospital
                  address:
                     name:Department of Laboratory Medicine, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, South Korea
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:BMC Cancer
      issn:
         1471-2407
      volumeNumber:13
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Incheon St. Mary’s Hospital
      address:
         name:Department of Internal Medicine, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, South Korea
         type:PostalAddress
      name:Incheon St. Mary’s Hospital
      address:
         name:Department of Internal Medicine, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, South Korea
         type:PostalAddress
      name:The Catholic University of Korea
      address:
         name:Division of Hepatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seocho-gu, South Korea
         type:PostalAddress
      name:Incheon St. Mary’s Hospital
      address:
         name:Department of Internal Medicine, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, South Korea
         type:PostalAddress
      name:Incheon St. Mary’s Hospital
      address:
         name:Department of Internal Medicine, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, South Korea
         type:PostalAddress
      name:Incheon St. Mary’s Hospital
      address:
         name:Department of Internal Medicine, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, South Korea
         type:PostalAddress
      name:The Catholic University of Korea
      address:
         name:Department of Radiation Oncology, The Catholic University of Korea, Incheon, South Korea
         type:PostalAddress
      name:Incheon St. Mary’s Hospital
      address:
         name:Department of Radiology, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, South Korea
         type:PostalAddress
      name:The Catholic University of Korea, Incheon St. Mary’s Hospital
      address:
         name:Department of Laboratory Medicine, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, South Korea
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Byong Sun Oh
      affiliation:
            name:Incheon St. Mary’s Hospital
            address:
               name:Department of Internal Medicine, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, South Korea
               type:PostalAddress
            type:Organization
      name:Jeong Won Jang
      affiliation:
            name:Incheon St. Mary’s Hospital
            address:
               name:Department of Internal Medicine, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, South Korea
               type:PostalAddress
            type:Organization
            name:The Catholic University of Korea
            address:
               name:Division of Hepatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seocho-gu, South Korea
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Jung Hyun Kwon
      affiliation:
            name:Incheon St. Mary’s Hospital
            address:
               name:Department of Internal Medicine, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, South Korea
               type:PostalAddress
            type:Organization
      name:Chan Ran You
      affiliation:
            name:Incheon St. Mary’s Hospital
            address:
               name:Department of Internal Medicine, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, South Korea
               type:PostalAddress
            type:Organization
      name:Kyu Won Chung
      affiliation:
            name:Incheon St. Mary’s Hospital
            address:
               name:Department of Internal Medicine, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, South Korea
               type:PostalAddress
            type:Organization
      name:Chul Seung Kay
      affiliation:
            name:The Catholic University of Korea
            address:
               name:Department of Radiation Oncology, The Catholic University of Korea, Incheon, South Korea
               type:PostalAddress
            type:Organization
      name:Hyun Suk Jung
      affiliation:
            name:Incheon St. Mary’s Hospital
            address:
               name:Department of Radiology, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, South Korea
               type:PostalAddress
            type:Organization
      name:Seungok Lee
      affiliation:
            name:The Catholic University of Korea, Incheon St. Mary’s Hospital
            address:
               name:Department of Laboratory Medicine, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, South Korea
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Internal Medicine, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, South Korea
      name:Department of Internal Medicine, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, South Korea
      name:Division of Hepatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seocho-gu, South Korea
      name:Department of Internal Medicine, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, South Korea
      name:Department of Internal Medicine, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, South Korea
      name:Department of Internal Medicine, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, South Korea
      name:Department of Radiation Oncology, The Catholic University of Korea, Incheon, South Korea
      name:Department of Radiology, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, South Korea
      name:Department of Laboratory Medicine, The Catholic University of Korea, Incheon St. Mary’s Hospital, Incheon, South Korea

External Links {🔗}(140)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

5.24s.